Study Data Show INTUNIV(TM) (Guanfacine) Extended Release Tablets Co-Administered With Stimulants Provided ADHD …

Munsch is ‘100 per cent on track’
Publishers, agent say the famed children’s author won’t miss any live appearances after confession of past alcohol and drug abuse

Read more on The Globe and Mail

Scholarships target drug abuse
MARLBORO — Donna Esposito, Middletown, lost her son Frank Mongelli Jr. to an accidental overdose of Oxycontin at a party on March 9, 2009.

Read more on Asbury Park Press

Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD …
NEW ORLEANS, May 21 /PRNewswire-FirstCall/ — Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV(TM) (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), at a major psychiatric meeting.

Read more on redOrbit

Related Drug Addiction Blogs

Subscribe to Our Feed!

Enter your email address:

Delivered by FeedBurner